Evidence map›Paper›PMID 35527322›Full record

ArticleVirchows Archiv : an international journal of pathology2022

Identification of a novel translocation producing an in-frame fusion of TAF15 and ETV4 in a case of extraosseous Ewing sarcoma revealed in the prenatal period.

Cécile Picard, Nicolas Macagno, Nadège Corradini, Perrine Marec-Bérard, Sara Cabet, Laurent Guibaud, Loic Viremouneix, Sébastien Raux, Franck Chotel, Nicolas Weinbreck and 5 more

Open access · greenAbstract readCase Reports
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 1 country.

Cécile PicardInstitut de Pathologie Multisite, Site Est, Hospices Civils de Lyon, Lyon, France. cecile.picard@chu-lyon.fr.ORCID http://orcid.org/0000-0001-9284-4531
Nicolas MacagnoDepartment of Biopathology, UNICANCER, Centre Leon Bérard, Lyon, France.
Nadège CorradiniDepartment of Pediatric Oncology, Centre Léon Bérard, Institut d'Hematologie Et d'Oncologie Pédiatrique, Lyon, France.
Perrine Marec-BérardDepartment of Pediatric Oncology, Centre Léon Bérard, Institut d'Hematologie Et d'Oncologie Pédiatrique, Lyon, France.
Sara CabetConsultation Des Angiomes, Centre de Compétence Des Malformations Vasculaires Superficielles, Service d Imagerie Pédiatrique, Hôpital Femme-Mère-Enfant, Bron, France.
Laurent GuibaudConsultation Des Angiomes, Centre de Compétence Des Malformations Vasculaires Superficielles, Service d Imagerie Pédiatrique, Hôpital Femme-Mère-Enfant, Bron, France.
Loic ViremouneixConsultation Des Angiomes, Centre de Compétence Des Malformations Vasculaires Superficielles, Service d Imagerie Pédiatrique, Hôpital Femme-Mère-Enfant, Bron, France.
Sébastien RauxDepartment of Paediatric Orthopaedic Surgery, Hôpital Femme-Mère-Enfant de Lyon, Hospices Civils de Lyon, Université Claude-Bernard Lyon 1, 69500, Bron, France.
Franck ChotelDepartment of Paediatric Orthopaedic Surgery, Hôpital Femme-Mère-Enfant de Lyon, Hospices Civils de Lyon, Université Claude-Bernard Lyon 1, 69500, Bron, France.
Nicolas WeinbreckMedipath Fréjus-Saint-Raphael, Pôle d'Excellence Jean Louis, 263 via Nova, Frejus, France.
Alexandra MeurgeyDepartment of Biopathology, UNICANCER, Centre Leon Bérard, Lyon, France.
Marie KaranianDepartment of Biopathology, UNICANCER, Centre Leon Bérard, Lyon, France.
Daniel PissalouxDepartment of Biopathology, UNICANCER, Centre Leon Bérard, Lyon, France.
Frank TirodeCentre Léon Bérard, Université Lyon, Université Claude Bernard Lyon 1, CNRS 5286, Cancer Research Center of Lyon, INSERM 1052, Lyon, France.
Frédérique DijoudInstitut de Pathologie Multisite, Site Est, Hospices Civils de Lyon, Lyon, France.
Centre Léon Bérard · FRHôpital Femme Mère Enfant · FRUniversité Claude Bernard Lyon 1 · FRHospices Civils de Lyon · FRInstitut d’Hématologie et d’Oncologie Pédiatrique · FRCentre Hospitalier Intercommunal de Fréjus Saint-Raphaël · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ewing sarcoma (ES) is a highly malignant round cell sarcoma, characterized by gene fusion involving FET (FUS, EWSR1, TAF15) and ETS family genes, respectively. The involvement of the EWSR1 gene has been reported in approximately 90% of cases of ES, with the EWSR1::FLI1 fusion being the most frequent. We report the case of a newborn with a localized soft tissue paravertebral neoplasm diagnosed prenatally. Histopathology and immunophenotype were consistent with a CD99 + , NKX2.2 + undifferentiated round cell sarcoma (URSC); whole-exome RNA-sequencing demonstrated an undescribed in-frame TAF15::ETV4 fusion transcript, while consensus clustering analysis showed high transcriptomic proximity to the ES group. Given clinical context, high tumor chemosensitivity to ES conventional drugs, morphological characteristics, nature of the fusion partners involved, and high transcriptomic proximity to bona fide ESs, this case may represent a new genetic variant of ES.

Indexed as

SarcomaSarcoma, EwingSoft Tissue NeoplasmsTATA-Binding Protein Associated FactorsGene FusionHumansInfant, NewbornOncogene Proteins, FusionProto-Oncogene Proteins c-etsRNARNA-Binding Protein EWSTranslocation, GeneticETV4 protein, humanOncogene Proteins, FusionProto-Oncogene Proteins c-etsRNARNA-Binding Protein EWSTAF15 protein, humanTATA-Binding Protein Associated FactorsETV4Ewing sarcomaPediatricTAF15TAF15::ETV4URSC

Identifiers

PMID35527322
OpenAlexW4229365161

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.